Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 616 across all filing types
Latest filing 2024-07-30 Regulatory Filings
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Informacja dotycząca wyboru projektu do dofinansowania - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is a short announcement (1060 characters) from the Management Board (Zarząd) of BioMaxima S.A. It informs the public that a funding application for participation in international trade fairs (Medlab, Medica, Analityca) has been approved for co-financing from the European Regional Development Fund (EFRR). This announcement concerns the securing of funds for future business activities, specifically international expansion via trade shows. This fits best under 'Capital/Financing Update' (CAP) as it relates to securing external funding/grants for operations, although it is not a traditional debt/equity financing event. Given the short length and the nature of announcing a positive outcome of a funding application, it is a specific corporate announcement. It is not an ER, IR, 10-K, or a simple report publication announcement (RPA) because it details the outcome of a specific funding application, not just the release of a report.
2024-07-30 Polish
Wykaz
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is in Polish and presents a 'Wykaz akcjonariuszy' (List of shareholders) holding at least 5% of the votes at the General Meeting ('Walnym Zgromadzeniu') held on June 24, 2024. This document explicitly details the voting power and shareholding percentages of major shareholders during a general meeting. This directly relates to the results of a shareholder vote, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA). It is not a full report (10-K, IR), an earnings release (ER), or a management presentation (IP).
2024-06-25 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% głosów poczas walnego zgromadzenia w dniu 24 czerwca 2024 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is very short (181 characters) and states that BioMaxima SA is making public a list of shareholders who held at least 5% of the votes during the general meeting held on June 24, 2024. This content relates to the results of a shareholder vote at a general meeting. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not a full report, but a specific announcement of results.
2024-06-25 Polish
Uchwały podjęte przez ZWZ BioMaxima SA 24.6.2024 r.
AGM Information Classification · 99% confidence The document text consists entirely of numbered resolutions ('Uchwała Nr X') passed during a 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) of 'BIOMAXIMA' S.A. on June 24, 2024. These resolutions cover the approval of the 2023 Management Board Report, the 2023 Consolidated Financial Statements, the approval of the Supervisory Board Report, and the granting of discharge ('pokwitowania') to various board members for their duties in 2023. The core content is the formal record of decisions made at the Annual General Meeting (AGM). This directly corresponds to the definition of AGM Information (AGM-R). Although financial statements are mentioned, the document itself is the record of the meeting where they were approved, not the statements or the annual report (10-K) itself.
2024-06-24 Polish
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie BioMaxima SA w dniu 24 czerwca 2024 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document text is very short (413 characters) and explicitly states that the management ('Zarząd') is enclosing ('przekazuje w załączeniu') the content of the resolutions ('treść uchwał') adopted during the Annual General Meeting ('Zwyczajnego Walnego Zgromadzenia Spółki') held on June 24, 2024. This structure—a brief announcement enclosing the main content—strongly suggests it is an announcement about the meeting results rather than the full set of resolutions or a comprehensive report. Since the content relates directly to the resolutions passed at the AGM, the most appropriate classification is 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it details the outcome of the votes taken at the meeting. It is not a general AGM presentation (AGM-R) but a specific declaration of results.
2024-06-24 Polish
Sprawozdanie o wynagrodzeniach
Remuneration Information Classification · 98% confidence The document title is "Sprawozdanie o wynagrodzeniach 2023" (Remuneration Report 2023). The text explicitly details the remuneration policies, fixed and variable compensation for the Management Board (Zarząd) and the Supervisory Board (Rada Nadzorcza) for the year 2023, referencing Polish regulations (Ustawa o Ofercie) concerning remuneration disclosures. This content directly aligns with the definition of a Remuneration Information report, which corresponds to the DEF 14A code in the provided schema, even though the document is in Polish and relates to a non-US entity, as the content focus is remuneration disclosure.
2024-05-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.